Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
- PMID: 23457019
- DOI: 10.1002/mds.25421
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Abstract
Background: Alpha-synuclein plays a central role in the pathophysiology of Parkinson's disease. Three missense mutations in SNCA, the gene encoding alpha-synuclein, as well as genomic multiplications have been identified as causes for autosomal-dominantly inherited Parkinsonism.
Methods: Here, we describe a novel missense mutation in exon 4 of SNCA encoding a H50Q substitution in a patient with dopa-responsive Parkinson's disease with a family history of parkinsonism and dementia.
Results: The variant was not observed in public databases or identified in unrelated subjects.
Conclusions: The substitution's evolutionary conservation and protein modeling provide additional support for pathogenicity as the amino acid perturbs the same amphipathic alpha helical structure as the previously described pathogenic mutations.
Copyright © 2013 Movement Disorder Society.
Similar articles
-
Parkinson disease: α-synuclein mutational screening and new clinical insight into the p.E46K mutation.Parkinsonism Relat Disord. 2015 Jun;21(6):586-9. doi: 10.1016/j.parkreldis.2015.03.011. Epub 2015 Mar 14. Parkinsonism Relat Disord. 2015. PMID: 25817515
-
Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.J Neurochem. 2014 Dec;131(6):859-67. doi: 10.1111/jnc.12806. Epub 2014 Jul 21. J Neurochem. 2014. PMID: 24984882
-
[Relationship between alpha-synuclein and Parkinson's disease].Brain Nerve. 2007 Aug;59(8):825-30. Brain Nerve. 2007. PMID: 17713118 Review. Japanese.
-
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.Mol Neurodegener. 2015 Aug 27;10:41. doi: 10.1186/s13024-015-0038-3. Mol Neurodegener. 2015. PMID: 26306801 Free PMC article.
-
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
Cited by
-
Structural insights into α-synuclein monomer-fibril interactions.Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2012171118. doi: 10.1073/pnas.2012171118. Proc Natl Acad Sci U S A. 2021. PMID: 33649211 Free PMC article.
-
Alpha-synuclein modulates dopamine neurotransmission.J Chem Neuroanat. 2017 Oct;83-84:41-49. doi: 10.1016/j.jchemneu.2016.06.001. Epub 2016 Jun 19. J Chem Neuroanat. 2017. PMID: 27334403 Free PMC article. Review.
-
Advances in the genetics of Parkinson disease.Nat Rev Neurol. 2013 Aug;9(8):445-54. doi: 10.1038/nrneurol.2013.132. Epub 2013 Jul 16. Nat Rev Neurol. 2013. PMID: 23857047 Review.
-
Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.Mov Disord. 2013 Jun;28(6):705-12. doi: 10.1002/mds.25502. Epub 2013 May 14. Mov Disord. 2013. PMID: 23674490 Free PMC article.
-
Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models.Open Biol. 2018 Sep;8(9):180138. doi: 10.1098/rsob.180138. Open Biol. 2018. PMID: 30185603 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
